Retatrutide and Triple-Receptor Agonism: What the Early Studies Established
A research retrospective on the triple-agonist concept, from discovery work to the 2023 phase 2 obesity trial, with clear limits on interpretation.
Read articleTHE CELLUPEP JOURNAL
Tag: Clinical Research
Company updates, practical sourcing guides and a closer look at peptide supply.
2 articles
Tirzepatide Research: Reading the Evidence Behind Dual Incretin Agonism
A focused reading of the 2021 and 2022 tirzepatide trials: why study population, comparator and endpoints matter as much as the headline result.
Read article